The global human microbiome market is expected to grow with a CAGR of 22%-24% by 2025


   January 13, 2021
According to a new market report published by Lucintel, the future of the human microbiome market looks promising with opportunities in the therapeutic industry. The global human microbiome market is expected to grow with a CAGR of 22%-24% from 2020 to 2025. The major drivers for this market are rise in advanced technology, increase in the aging population, rise in incidences of chronic diseases, and regulations by governmental bodies on probiotics and prebiotics.

The human microbiome is the aggregate of all microbiota that reside on or within human tissues and biofluids along with the corresponding anatomical sites in which they reside, including the skin, mammary glands, placenta, seminal fluid, uterus, ovarian follicles, lung, saliva, oral mucosa, conjunctiva, biliary tract, and gastrointestinal tract. In this market, proteomics, metabolomics, and genomics are the major research technologies of human microbiome. Lucintel forecasts that genomics will remain the largest research technology segment over the forecast period due to increasing number of projects funded by private and government bodies.

Within this market, therapeutic will remain the largest application segment over the forecast period due to the increase in funding for R&D into microbiome-based therapies.

North America is expected to witness the highest growth over the forecast period due to increasing incidences of lifestyle diseases, rising awareness of preventive healthcare, availability of funding for microbiome research, and growing acceptance of probiotic products. 

Enterome Bioscience, Seres Therapeutics, 4D Pharma, Rebiotix, Yakult Honsha, Osel, Vedanta Biosciences, Synthetic Biologics, DuPont, and BiomX are among the major suppliers in the global human microbiome market.

Lucintel, a leading global strategic consulting and market research firm, has analyzed growth opportunities in the global human microbiome market by product, disease, application, research technology, and region. Lucintel has prepared a comprehensive research report titled “Growth Opportunities in the Global Human Microbiome Market 2020-2025: Trends, Forecast, and Opportunity Analysis.” This Lucintel report serves as a catalyst for growth strategy, as it provides comprehensive data and analysis on trends, key drivers, and directions. The study includes trends and forecast for the global human microbiome market by product, disease, application, research technology, and region as follows:

By Product [Value ($ Million) shipment analysis for 2014 – 2025]:



  • Prebiotic


  • Probiotic


  • Food


  • Medical Food


  • Drug


By Disease [Value ($ Million) shipment analysis for 2014 – 2025]:



  • Infectious


  • Metabolic/Endocrine


  • Cancer


  • Blood


  • Neurological


 

By Research Technology [Value ($ Million) shipment analysis for 2014 – 2025]:



  • Proteomics


  • Metabolomics


  • Genomics


By Region [Value ($ Million) shipment analysis for 2014 – 2025]:



  • North America




  • United States


  • Canada


  • Mexico




  • Europe




  • United Kingdom


  • Spain


  • Germany


  • France




  • Asia Pacific




  • China


  • India


  • Japan


  • Indonesia




  • The Rest of the World




  • Brazil


 

This 150-page research report will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or visit us at helpdesk@lucintel.com.

About Lucintel

Lucintel, the premier global Management Consulting and market research firm, creates winning strategies for growth. It offers market assessments, competitive analysis, opportunity analysis, Growth Consulting, M&A, and Due diligence services to executives and key decision makers in a variety of industries. For further information, visit www.lucintel.com.

Lucintel Corporate Customers

Market Entry, M & A, Opportunity Screening,...

Private Equity Customers

Buy Side Services (target screening, due diligence, ..)

Customer Quotes

"With more than 20 years experience in the industry, this is the first time we have come across such an extensive market analysis for our industry." Ven Cote, CEO, ZCL

"The insights we gained from Lucintel work helped with our business plan…a wonderful professional job…" Mike Jackson, Stahlin

"The report from Lucintel is useful not only for business planners, but also for the technology officers wanting to create a roadmap …" Dr. Giulio Ranzo, Booz Allen

"The information is so comprehensive, it has allowed us to identify & focus our business development efforts. It saved months of leg-work." Bill Barz, L&L Products

"We bought Lucintel report because it is the best report about our industry…a complete and appropriate analysis." Cesare Andrenacci, Ferretti